SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-742225
Filing Date
2016-10-20
Accepted
2016-10-20 07:10:55
Documents
4
Period of Report
2016-10-19
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d270461d8k.htm 8-K 24505
2 EX-99.1 d270461dex991.htm EX-99.1 11781
3 EX-99.2 d270461dex992.htm EX-99.2 11803
4 GRAPHIC g270461snap1.jpg GRAPHIC 2924
  Complete submission text file 0001193125-16-742225.txt   53613
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 161943514
SIC: 2834 Pharmaceutical Preparations